LHCFX
Price
$17.98
Change
-$0.44 (-2.39%)
Updated
Apr 3 closing price
Net Assets
7.48M
SHSAX
Price
$63.37
Change
-$0.71 (-1.11%)
Updated
Apr 3 closing price
Net Assets
7.08B
Ad is loading...

LHCFX vs SHSAX

Header iconLHCFX vs SHSAX Comparison
Open Charts LHCFX vs SHSAXBanner chart's image
Lord Abbett Health Care F
Price$17.98
Change-$0.44 (-2.39%)
VolumeN/A
Net Assets7.48M
BlackRock Health Sciences Opps Inv A
Price$63.37
Change-$0.71 (-1.11%)
VolumeN/A
Net Assets7.08B
LHCFX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LHCFX vs. SHSAX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LHCFX is a Buy and SHSAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 7.08B vs. LHCFX (7.48M). LHCFX pays higher dividends than SHSAX: LHCFX (0.48) vs SHSAX (0.21). LHCFX was incepted earlier than SHSAX: LHCFX (6 years) vs SHSAX (25 years). LHCFX (3.38) is less costly to investors than SHSAX (1.09). LHCFX is a more actively managed with annual turnover of: 88.00 vs. SHSAX (27.00). LHCFX has a lower initial minimum investment than SHSAX: LHCFX (0) vs SHSAX (1000). LHCFX annual gain was more profitable for investors over the last year : -3.45 vs. SHSAX (-7.49). LHCFX return over 5 years is better than : 32.42 vs. SHSAX (16.14).
LHCFXSHSAXLHCFX / SHSAX
Total Expense Ratio0.781.0972%
Annual Report Gross Expense Ratio3.381.09310%
Fund Existence6 years25 years-
Gain YTD-5.0522.627-192%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.48M7.08B0%
Annual Yield % from dividends0.480.21224%
Returns for 1 year-3.45-7.4946%
Returns for 3 years-1.02-9.4411%
Returns for 5 years32.4216.14201%
Returns for 10 yearsN/A21.61-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FUNCX26.68N/A
N/A
Pioneer Fundamental Growth C
VNSYX20.97N/A
N/A
Natixis Vaughan Nelson Select Y
JSPJX18.69N/A
N/A
Jackson Square Large-Cap Growth Inv
FHOFX23.27N/A
N/A
Fidelity Series Large Cp Grwth Idx
MEGMX13.37N/A
N/A
Matthews Emerging Markets Equity Inv